| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid binding | 1.48e-08 | 28 | 20 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 3.76e-08 | 35 | 20 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | retinoid binding | 1.38e-07 | 48 | 20 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 1.51e-07 | 49 | 20 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 5.07e-07 | 66 | 20 | 4 | GO:0005080 | |
| GeneOntologyMolecularFunction | fatty acid binding | 6.07e-07 | 69 | 20 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 3.15e-06 | 239 | 20 | 5 | GO:0031406 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 3.53e-06 | 107 | 20 | 4 | GO:0033293 | |
| GeneOntologyMolecularFunction | organic acid binding | 4.25e-06 | 254 | 20 | 5 | GO:0043177 | |
| GeneOntologyMolecularFunction | steroid binding | 8.39e-06 | 133 | 20 | 4 | GO:0005496 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 1.46e-05 | 153 | 20 | 4 | GO:0008194 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 5.14e-05 | 211 | 20 | 4 | GO:0016758 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 1.71e-04 | 288 | 20 | 4 | GO:0016757 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 5.85e-04 | 398 | 20 | 4 | GO:0046982 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 8.16e-04 | 435 | 20 | 4 | GO:0004857 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | 2.60e-03 | 596 | 20 | 4 | GO:0140678 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 7.19e-03 | 1271 | 20 | 5 | GO:0000987 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 7.91e-03 | 815 | 20 | 4 | GO:0042803 | |
| GeneOntologyMolecularFunction | protein kinase binding | 1.00e-02 | 873 | 20 | 4 | GO:0019901 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 1.11e-02 | 1412 | 20 | 5 | GO:0000981 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 3.97e-12 | 5 | 21 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 1.19e-11 | 6 | 21 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 1.19e-11 | 6 | 21 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 1.19e-11 | 6 | 21 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 1.66e-10 | 10 | 21 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 1.66e-10 | 10 | 21 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 5.64e-10 | 13 | 21 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 4.70e-09 | 21 | 21 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 4.70e-09 | 21 | 21 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 9.08e-09 | 5 | 21 | 3 | GO:0052696 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.17e-08 | 26 | 21 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.17e-08 | 26 | 21 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 3.61e-08 | 34 | 21 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 1.99e-07 | 12 | 21 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 2.08e-07 | 52 | 21 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 5.84e-07 | 67 | 21 | 4 | GO:0019748 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 2.28e-06 | 94 | 21 | 4 | GO:0042440 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 8.77e-06 | 40 | 21 | 3 | GO:0042573 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 1.14e-05 | 141 | 21 | 4 | GO:0006805 | |
| GeneOntologyBiologicalProcess | liver development | 4.69e-05 | 202 | 21 | 4 | GO:0001889 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 4.97e-05 | 205 | 21 | 4 | GO:0061008 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 6.77e-05 | 222 | 21 | 4 | GO:0071466 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 9.76e-05 | 89 | 21 | 3 | GO:0001523 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 1.15e-04 | 94 | 21 | 3 | GO:0016101 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 1.59e-04 | 105 | 21 | 3 | GO:0006721 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 1.80e-04 | 286 | 21 | 4 | GO:0042445 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 4.04e-04 | 144 | 21 | 3 | GO:0006720 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 5.09e-04 | 376 | 21 | 4 | GO:0008202 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | 5.40e-04 | 382 | 21 | 4 | GO:0016042 | |
| GeneOntologyBiologicalProcess | single fertilization | 1.19e-03 | 209 | 21 | 3 | GO:0007338 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 1.76e-03 | 525 | 21 | 4 | GO:0009410 | |
| GeneOntologyBiologicalProcess | gland development | 2.20e-03 | 558 | 21 | 4 | GO:0048732 | |
| GeneOntologyBiologicalProcess | cilium movement | 2.25e-03 | 261 | 21 | 3 | GO:0003341 | |
| GeneOntologyBiologicalProcess | fertilization | 2.30e-03 | 263 | 21 | 3 | GO:0009566 | |
| Domain | UDPGT | 4.53e-09 | 21 | 19 | 4 | PS00375 | |
| Domain | UDPGT | 4.53e-09 | 21 | 19 | 4 | PF00201 | |
| Domain | UDP_glucos_trans | 4.53e-09 | 21 | 19 | 4 | IPR002213 | |
| Domain | - | 4.34e-03 | 679 | 19 | 4 | 3.30.160.60 | |
| Domain | zf-C2H2 | 4.67e-03 | 693 | 19 | 4 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 4.69e-03 | 694 | 19 | 4 | IPR013087 | |
| Domain | ZINC_FINGER_C2H2_2 | 6.93e-03 | 775 | 19 | 4 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 6.99e-03 | 777 | 19 | 4 | PS00028 | |
| Domain | Znf_C2H2-like | 7.61e-03 | 796 | 19 | 4 | IPR015880 | |
| Domain | Znf_C2H2 | 7.91e-03 | 805 | 19 | 4 | IPR007087 | |
| Domain | ZnF_C2H2 | 8.01e-03 | 808 | 19 | 4 | SM00355 | |
| Pathway | WP_ESTROGEN_METABOLISM | 8.00e-09 | 22 | 16 | 4 | MM15888 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.16e-08 | 24 | 16 | 4 | MM14599 | |
| Pathway | WP_GLUCURONIDATION | 1.38e-08 | 25 | 16 | 4 | MM15820 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.38e-08 | 25 | 16 | 4 | M17787 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 1.38e-08 | 25 | 16 | 4 | M605 | |
| Pathway | WP_GLUCURONIDATION | 1.63e-08 | 26 | 16 | 4 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 2.23e-08 | 28 | 16 | 4 | M19580 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 8.89e-08 | 39 | 16 | 4 | MM15695 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 1.09e-07 | 41 | 16 | 4 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.60e-07 | 45 | 16 | 4 | MM15694 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 2.68e-07 | 51 | 16 | 4 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 2.90e-07 | 52 | 16 | 4 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 3.64e-07 | 55 | 16 | 4 | M14933 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 4.33e-07 | 14 | 16 | 3 | M39328 | |
| Pathway | KEGG_RETINOL_METABOLISM | 6.75e-07 | 64 | 16 | 4 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 9.70e-07 | 70 | 16 | 4 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 1.09e-06 | 72 | 16 | 4 | M9257 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 5.32e-06 | 107 | 16 | 4 | MM14595 | |
| Pathway | REACTOME_DRUG_ADME | 5.73e-06 | 109 | 16 | 4 | M45012 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 5.73e-06 | 109 | 16 | 4 | M18788 | |
| Pathway | REACTOME_DRUG_ADME | 8.12e-06 | 119 | 16 | 4 | MM15692 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.54e-05 | 44 | 16 | 3 | M45014 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 1.78e-05 | 145 | 16 | 4 | M45512 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 2.19e-05 | 153 | 16 | 4 | MM15844 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 7.92e-05 | 12 | 16 | 2 | M39611 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 8.91e-05 | 219 | 16 | 4 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 9.07e-05 | 220 | 16 | 4 | M10320 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 2.50e-04 | 21 | 16 | 2 | M39631 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 3.29e-04 | 24 | 16 | 2 | M46445 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 4.82e-04 | 29 | 16 | 2 | M45015 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 1.06e-03 | 183 | 16 | 3 | M39588 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 1.16e-03 | 45 | 16 | 2 | M39615 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 4.94e-03 | 314 | 16 | 3 | M39428 | |
| Pubmed | 1.47e-12 | 6 | 21 | 4 | 20297805 | ||
| Pubmed | 1.47e-12 | 6 | 21 | 4 | 32527940 | ||
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 3.43e-12 | 7 | 21 | 4 | 8467709 | |
| Pubmed | 3.43e-12 | 7 | 21 | 4 | 8464825 | ||
| Pubmed | 3.43e-12 | 7 | 21 | 4 | 27514509 | ||
| Pubmed | 6.86e-12 | 8 | 21 | 4 | 17179145 | ||
| Pubmed | 6.86e-12 | 8 | 21 | 4 | 18052087 | ||
| Pubmed | 6.86e-12 | 8 | 21 | 4 | 20610558 | ||
| Pubmed | 1.23e-11 | 9 | 21 | 4 | 22511988 | ||
| Pubmed | 2.06e-11 | 10 | 21 | 4 | 23642732 | ||
| Pubmed | 2.06e-11 | 10 | 21 | 4 | 11465080 | ||
| Pubmed | 2.06e-11 | 10 | 21 | 4 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 2.06e-11 | 10 | 21 | 4 | 22558097 | |
| Pubmed | 4.85e-11 | 12 | 21 | 4 | 19419973 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 4.85e-11 | 12 | 21 | 4 | 20308471 | |
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 4.85e-11 | 12 | 21 | 4 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 7.00e-11 | 13 | 21 | 4 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 7.00e-11 | 13 | 21 | 4 | 25246029 | |
| Pubmed | 9.79e-11 | 14 | 21 | 4 | 21646302 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 9.79e-11 | 14 | 21 | 4 | 14672974 | |
| Pubmed | 9.79e-11 | 14 | 21 | 4 | 9295054 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 9.79e-11 | 14 | 21 | 4 | 10836148 | |
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 1.78e-10 | 16 | 21 | 4 | 19414484 | |
| Pubmed | 1.90e-10 | 3 | 21 | 3 | 12847094 | ||
| Pubmed | 1.90e-10 | 3 | 21 | 3 | 29519853 | ||
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 2.33e-10 | 17 | 21 | 4 | 20639394 | |
| Pubmed | 2.99e-10 | 18 | 21 | 4 | 20056724 | ||
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 3.78e-10 | 19 | 21 | 4 | 23281178 | |
| Pubmed | 7.59e-10 | 4 | 21 | 3 | 17558305 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 1.04e-09 | 24 | 21 | 4 | 24625756 | |
| Pubmed | 1.90e-09 | 5 | 21 | 3 | 20565459 | ||
| Pubmed | 1.90e-09 | 5 | 21 | 3 | 15057901 | ||
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 1.59e-08 | 9 | 21 | 3 | 20732626 | |
| Pubmed | 3.12e-08 | 11 | 21 | 3 | 18695635 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 3.80e-08 | 57 | 21 | 4 | 21886157 | |
| Pubmed | 6.91e-08 | 66 | 21 | 4 | 19898482 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 1.47e-07 | 211 | 21 | 5 | 24097068 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 11677206 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 22031623 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 9647757 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 17529886 | ||
| Pubmed | Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. | 3.47e-07 | 2 | 21 | 2 | 10497143 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 18568343 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 20089735 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 11901093 | ||
| Pubmed | Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes. | 3.47e-07 | 2 | 21 | 2 | 17603215 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 15709193 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 12944498 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 25547628 | ||
| Pubmed | Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. | 1.04e-06 | 3 | 21 | 2 | 20007669 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 19225446 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 23721685 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 19244109 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 19996319 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 23789755 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 26247833 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 16397224 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 19364970 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 17406868 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 17339869 | ||
| Pubmed | Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. | 1.04e-06 | 3 | 21 | 2 | 24453052 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 16636344 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 23700788 | ||
| Pubmed | Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1. | 2.08e-06 | 4 | 21 | 2 | 2108603 | |
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 18946804 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 9271343 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 20147615 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 20628391 | ||
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 17072959 | ||
| Pubmed | KAISO, a critical regulator of p53-mediated transcription of CDKN1A and apoptotic genes. | 3.47e-06 | 5 | 21 | 2 | 25288747 | |
| Pubmed | Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers. | 3.47e-06 | 5 | 21 | 2 | 18597651 | |
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 18556656 | ||
| Pubmed | 4.80e-06 | 190 | 21 | 4 | 24816252 | ||
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 5.20e-06 | 6 | 21 | 2 | 19204906 | |
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | 6.24e-06 | 203 | 21 | 4 | 16916647 | |
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 9.70e-06 | 8 | 21 | 2 | 12695355 | |
| Pubmed | 9.70e-06 | 8 | 21 | 2 | 15319294 | ||
| Pubmed | 1.25e-05 | 9 | 21 | 2 | 1339448 | ||
| Pubmed | Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. | 2.28e-05 | 12 | 21 | 2 | 19349540 | |
| Pubmed | 4.15e-05 | 16 | 21 | 2 | 20972438 | ||
| Pubmed | ICK is essential for cell type-specific ciliogenesis and the regulation of ciliary transport. | 9.51e-05 | 24 | 21 | 2 | 24797473 | |
| Pubmed | Genome-wide association study identifies multiple loci associated with bladder cancer risk. | 1.12e-04 | 26 | 21 | 2 | 24163127 | |
| Interaction | UGT1A9 interactions | 2.38e-07 | 13 | 20 | 3 | int:UGT1A9 | |
| Interaction | UGT1A7 interactions | 2.69e-07 | 57 | 20 | 4 | int:UGT1A7 | |
| Interaction | UGT1A8 interactions | 2.81e-06 | 3 | 20 | 2 | int:UGT1A8 | |
| Interaction | UGT1A10 interactions | 4.47e-06 | 33 | 20 | 3 | int:UGT1A10 | |
| Interaction | ZNF492 interactions | 7.25e-05 | 13 | 20 | 2 | int:ZNF492 | |
| Interaction | ZNF675 interactions | 8.45e-05 | 14 | 20 | 2 | int:ZNF675 | |
| Cytoband | 2q37 | 1.01e-09 | 31 | 21 | 4 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 3.20e-06 | 226 | 21 | 4 | chr2q37 | |
| Cytoband | 19p12 | 7.79e-04 | 90 | 21 | 2 | 19p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 1.42e-03 | 122 | 21 | 2 | chr19p12 | |
| GeneFamily | UDP glucuronosyltransferases | 3.07e-08 | 32 | 19 | 4 | 363 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 5.94e-03 | 718 | 19 | 4 | 28 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR | 6.34e-06 | 154 | 21 | 4 | MM1313 | |
| Coexpression | NFE2L2.V2 | 2.88e-05 | 469 | 21 | 5 | M2870 | |
| Drug | naringenin chalcone | 2.16e-12 | 5 | 20 | 4 | ctd:C027329 | |
| Drug | anthrarobin | 2.16e-12 | 5 | 20 | 4 | ctd:C032186 | |
| Drug | alloin | 6.49e-12 | 6 | 20 | 4 | ctd:C006457 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 6.49e-12 | 6 | 20 | 4 | ctd:C543211 | |
| Drug | 2',5'-dihydroxychalcone | 6.49e-12 | 6 | 20 | 4 | ctd:C107497 | |
| Drug | 2',4'-dihydroxychalcone | 1.51e-11 | 7 | 20 | 4 | ctd:C059354 | |
| Drug | 1,4-dihydroxyanthraquinone | 3.02e-11 | 8 | 20 | 4 | ctd:C034890 | |
| Drug | AC1MRQNQ | 5.44e-11 | 9 | 20 | 4 | CID003522271 | |
| Drug | DHPASiU | 5.44e-11 | 9 | 20 | 4 | CID000197602 | |
| Drug | Chebi:32663 | 5.44e-11 | 9 | 20 | 4 | CID005460873 | |
| Drug | 3-iodophenol | 5.44e-11 | 9 | 20 | 4 | CID000012272 | |
| Drug | AC1L4J7U | 5.44e-11 | 9 | 20 | 4 | CID000186631 | |
| Drug | indole-2-carboxylic acid | 6.04e-11 | 32 | 20 | 5 | CID000072899 | |
| Drug | 2,6-dihydroxyanthraquinone | 9.06e-11 | 10 | 20 | 4 | ctd:C034889 | |
| Drug | 4-nitrophenyl)imidazole | 1.42e-10 | 11 | 20 | 4 | CID000123155 | |
| Drug | AC1O5XMV | 1.42e-10 | 11 | 20 | 4 | CID006442661 | |
| Drug | levo-dromoran tartrate | 2.01e-10 | 98 | 20 | 6 | CID000003918 | |
| Drug | N-OH-DABZ | 2.13e-10 | 12 | 20 | 4 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 2.13e-10 | 12 | 20 | 4 | CID000088735 | |
| Drug | 7,7,7-triphenylheptanoic acid | 2.13e-10 | 12 | 20 | 4 | CID000276709 | |
| Drug | nonanoyl-N-methylglucamide | 2.13e-10 | 12 | 20 | 4 | CID000160090 | |
| Drug | 4-hydroxyestrone | 2.13e-10 | 12 | 20 | 4 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 2.13e-10 | 12 | 20 | 4 | CID000037247 | |
| Drug | 2-hydroxyestrone | 3.08e-10 | 13 | 20 | 4 | ctd:C024980 | |
| Drug | cotinine-N-glucuronide | 3.08e-10 | 13 | 20 | 4 | CID000000411 | |
| Drug | tritanol | 3.08e-10 | 13 | 20 | 4 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 3.08e-10 | 13 | 20 | 4 | CID003081279 | |
| Drug | alizarin | 3.08e-10 | 13 | 20 | 4 | ctd:C010078 | |
| Drug | propranolol glucuronide | 4.31e-10 | 14 | 20 | 4 | CID000119515 | |
| Drug | PCB-61 | 4.31e-10 | 14 | 20 | 4 | CID000036401 | |
| Drug | sulforaphane nitrile | 5.87e-10 | 15 | 20 | 4 | CID000543743 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 5.87e-10 | 15 | 20 | 4 | CID000040469 | |
| Drug | coumarin-3-carboxylic acid | 5.87e-10 | 15 | 20 | 4 | CID000010752 | |
| Drug | afloqualone | 5.87e-10 | 15 | 20 | 4 | CID000002040 | |
| Drug | bergamottin | 5.87e-10 | 15 | 20 | 4 | ctd:C068337 | |
| Drug | naphthyl sulphate | 5.87e-10 | 15 | 20 | 4 | CID000114775 | |
| Drug | quercetin-3,4'-diglucoside | 7.82e-10 | 16 | 20 | 4 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 7.82e-10 | 16 | 20 | 4 | CID000040003 | |
| Drug | bilirubin-phosphate | 7.82e-10 | 16 | 20 | 4 | CID005497144 | |
| Drug | DEPC | 8.50e-10 | 53 | 20 | 5 | CID000015357 | |
| Drug | Equol | 9.37e-10 | 54 | 20 | 5 | ctd:D060754 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 1.02e-09 | 17 | 20 | 4 | CID000003573 | |
| Drug | 6-hydroxychrysene | 1.02e-09 | 17 | 20 | 4 | CID000037766 | |
| Drug | SureCN12722713 | 1.31e-09 | 18 | 20 | 4 | CID005488034 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 1.31e-09 | 18 | 20 | 4 | CID000036614 | |
| Drug | ApApG | 1.31e-09 | 18 | 20 | 4 | CID003081975 | |
| Drug | C1 11-32 | 1.31e-09 | 18 | 20 | 4 | CID000443077 | |
| Drug | C11131 | 1.31e-09 | 18 | 20 | 4 | CID000443076 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 1.31e-09 | 18 | 20 | 4 | CID000152226 | |
| Drug | Br 2 | 1.31e-09 | 18 | 20 | 4 | CID003060900 | |
| Drug | almokalant | 1.66e-09 | 19 | 20 | 4 | CID003033962 | |
| Drug | 9-OH-risperidone | 1.66e-09 | 19 | 20 | 4 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 1.66e-09 | 19 | 20 | 4 | CID000091433 | |
| Drug | tectochrysin | 2.08e-09 | 20 | 20 | 4 | CID005281954 | |
| Drug | AC1L1OBF | 2.08e-09 | 20 | 20 | 4 | CID000032736 | |
| Drug | entacapone | 2.08e-09 | 20 | 20 | 4 | ctd:C071192 | |
| Drug | 4'-hydroxydiclofenac | 2.08e-09 | 20 | 20 | 4 | CID000116545 | |
| Drug | 2-vanillin | 2.32e-09 | 4 | 20 | 3 | ctd:C060843 | |
| Drug | diphenylacetic acid | 2.32e-09 | 4 | 20 | 3 | ctd:C037760 | |
| Drug | hydratropic acid | 2.32e-09 | 4 | 20 | 3 | ctd:C013025 | |
| Drug | estriol-16-glucuronide | 2.57e-09 | 21 | 20 | 4 | CID000122281 | |
| Drug | dulcin | 2.57e-09 | 21 | 20 | 4 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 2.57e-09 | 21 | 20 | 4 | CID000069186 | |
| Drug | plumbagin | 3.13e-09 | 22 | 20 | 4 | ctd:C014758 | |
| Drug | N-methylpiperazine | 3.13e-09 | 22 | 20 | 4 | CID000053167 | |
| Drug | amonafide | 3.13e-09 | 22 | 20 | 4 | CID000050515 | |
| Drug | amidoxime | 3.79e-09 | 23 | 20 | 4 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 3.79e-09 | 23 | 20 | 4 | CID000066651 | |
| Drug | phenanthridine | 3.79e-09 | 23 | 20 | 4 | CID000009189 | |
| Drug | AS-3201 | 4.55e-09 | 24 | 20 | 4 | CID000153948 | |
| Drug | 7-hydroxycoumarin | 5.05e-09 | 75 | 20 | 5 | CID005281426 | |
| Drug | N-acetylbenzidine | 5.41e-09 | 25 | 20 | 4 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 5.41e-09 | 25 | 20 | 4 | CID000006796 | |
| Drug | 5-MOP | 5.41e-09 | 25 | 20 | 4 | CID000002355 | |
| Drug | N-phenylmaleimide | 5.41e-09 | 25 | 20 | 4 | CID000013662 | |
| Drug | Hymecromone | 5.41e-09 | 25 | 20 | 4 | ctd:D006923 | |
| Drug | AzMC | 5.41e-09 | 25 | 20 | 4 | CID000064986 | |
| Drug | isovaleric acid | 5.79e-09 | 5 | 20 | 3 | ctd:C008216 | |
| Drug | biphenylylacetic acid | 5.79e-09 | 5 | 20 | 3 | ctd:C012776 | |
| Drug | Thymol | 6.39e-09 | 26 | 20 | 4 | ctd:D013943 | |
| Drug | licochalcone A | 7.50e-09 | 27 | 20 | 4 | ctd:C070840 | |
| Drug | Scopoletin | 7.50e-09 | 27 | 20 | 4 | ctd:D012603 | |
| Drug | DiMeIQx | 7.50e-09 | 27 | 20 | 4 | CID000104739 | |
| Drug | diflunisal | 7.50e-09 | 27 | 20 | 4 | CID000003059 | |
| Drug | N-hydroxy-4-aminobiphenyl | 8.74e-09 | 28 | 20 | 4 | CID000081261 | |
| Drug | erucin | 8.74e-09 | 28 | 20 | 4 | CID000078160 | |
| Drug | H-Ni | 8.74e-09 | 28 | 20 | 4 | CID000445665 | |
| Drug | CARMINE | 8.74e-09 | 28 | 20 | 4 | CID000014749 | |
| Drug | AC1L1JAL | 1.01e-08 | 29 | 20 | 4 | CID000004954 | |
| Drug | trans-3'-hydroxycotinine | 1.01e-08 | 29 | 20 | 4 | CID000000414 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 1.01e-08 | 29 | 20 | 4 | CID005375667 | |
| Drug | 7-hydroxycoumarin glucuronide | 1.01e-08 | 29 | 20 | 4 | CID000125641 | |
| Drug | iberin | 1.01e-08 | 29 | 20 | 4 | CID000010455 | |
| Drug | 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine | 1.01e-08 | 29 | 20 | 4 | ctd:C060533 | |
| Drug | 3-phenylpropionic acid | 1.16e-08 | 6 | 20 | 3 | ctd:C035253 | |
| Drug | Indoprofen | 1.16e-08 | 6 | 20 | 3 | ctd:D007216 | |
| Drug | paricalcitol | 1.17e-08 | 30 | 20 | 4 | CID005281104 | |
| Drug | AC1L9E0Q | 1.17e-08 | 30 | 20 | 4 | CID000443095 | |
| Drug | dihydroartemisinin | 1.17e-08 | 30 | 20 | 4 | CID000107770 | |
| Drug | tolcapone | 1.17e-08 | 30 | 20 | 4 | CID004659569 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 7.67e-13 | 5 | 20 | 4 | EFO_0801060 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 7.67e-13 | 5 | 20 | 4 | EFO_0801853 | |
| Disease | 5-hydroxyindole sulfate measurement | 7.67e-13 | 5 | 20 | 4 | EFO_0800085 | |
| Disease | X-21339 measurement | 5.36e-12 | 7 | 20 | 4 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 1.07e-11 | 8 | 20 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 1.07e-11 | 8 | 20 | 4 | EFO_0022118 | |
| Disease | X-24849 measurement | 1.07e-11 | 8 | 20 | 4 | EFO_0800909 | |
| Disease | cholelithiasis, bilirubin measurement | 1.07e-11 | 8 | 20 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11530 measurement | 1.07e-11 | 8 | 20 | 4 | EFO_0021249 | |
| Disease | X-11522 measurement | 1.07e-11 | 8 | 20 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 1.07e-11 | 8 | 20 | 4 | EFO_0800692 | |
| Disease | serum N-desmethylclozapine measurement | 1.07e-11 | 8 | 20 | 4 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 1.07e-11 | 8 | 20 | 4 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 1.07e-11 | 8 | 20 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 1.07e-11 | 8 | 20 | 4 | EFO_0800766 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 1.07e-11 | 8 | 20 | 4 | EFO_0801034 | |
| Disease | X-11442 measurement | 1.93e-11 | 9 | 20 | 4 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.93e-11 | 9 | 20 | 4 | EFO_0021235 | |
| Disease | X-11880 measurement | 1.93e-11 | 9 | 20 | 4 | EFO_0800698 | |
| Disease | circulating cell free DNA measurement | 1.93e-11 | 9 | 20 | 4 | EFO_0004739 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.93e-11 | 9 | 20 | 4 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.93e-11 | 9 | 20 | 4 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.93e-11 | 9 | 20 | 4 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.93e-11 | 9 | 20 | 4 | EFO_0801036 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.93e-11 | 9 | 20 | 4 | EFO_0004570, GO_0009410 | |
| Disease | X-21448 measurement | 3.21e-11 | 10 | 20 | 4 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 3.21e-11 | 10 | 20 | 4 | EFO_0802185 | |
| Disease | bilirubin measurement, response to tenofovir | 3.21e-11 | 10 | 20 | 4 | EFO_0004570, EFO_0009279 | |
| Disease | X-23974 measurement | 3.21e-11 | 10 | 20 | 4 | EFO_0800867 | |
| Disease | pregnenetriol sulfate measurement | 5.05e-11 | 11 | 20 | 4 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 5.05e-11 | 11 | 20 | 4 | EFO_0600039 | |
| Disease | insomnia, bilirubin measurement | 5.05e-11 | 11 | 20 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | histidine betaine (hercynine) measurement | 5.05e-11 | 11 | 20 | 4 | EFO_0800972 | |
| Disease | aldosterone measurement | 5.05e-11 | 11 | 20 | 4 | EFO_0010219 | |
| Disease | X-21796 measurement | 5.05e-11 | 11 | 20 | 4 | EFO_0800825 | |
| Disease | biliverdin measurement | 7.57e-11 | 12 | 20 | 4 | EFO_0021033 | |
| Disease | p-cresol glucuronide measurement | 7.57e-11 | 12 | 20 | 4 | EFO_0800079 | |
| Disease | pregnenetriol disulfate measurement | 1.09e-10 | 13 | 20 | 4 | EFO_0800587 | |
| Disease | retinol dehydrogenase 16 measurement | 1.09e-10 | 13 | 20 | 4 | EFO_0802007 | |
| Disease | blood 4-oxo-retinoic acid measurement | 2.66e-10 | 3 | 20 | 3 | EFO_0022216 | |
| Disease | indole-3-carboxylate measurement | 2.66e-10 | 3 | 20 | 3 | EFO_0800043 | |
| Disease | X-21441 measurement | 3.63e-10 | 17 | 20 | 4 | EFO_0800814 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 3.63e-10 | 17 | 20 | 4 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 4.67e-10 | 18 | 20 | 4 | EFO_0801382 | |
| Disease | tissue factor measurement | 9.11e-10 | 21 | 20 | 4 | EFO_0010623 | |
| Disease | neuroblastoma, cutaneous melanoma | 3.11e-09 | 28 | 20 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | xanthurenate measurement | 3.60e-09 | 29 | 20 | 4 | EFO_0010551 | |
| Disease | response to dolutegravir | 4.16e-09 | 30 | 20 | 4 | EFO_0600017 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 5.32e-09 | 6 | 20 | 3 | EFO_0800566 | |
| Disease | vitamin D deficiency | 9.99e-09 | 37 | 20 | 4 | EFO_0003762 | |
| Disease | indoleacetate measurement | 3.19e-08 | 10 | 20 | 3 | EFO_0021015 | |
| Disease | vitamin D measurement, COVID-19 | 3.19e-08 | 49 | 20 | 4 | EFO_0004631, MONDO_0100096 | |
| Disease | urate measurement, spine bone mineral density | 6.36e-08 | 58 | 20 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | X-24588 measurement | 7.58e-08 | 13 | 20 | 3 | EFO_0800898 | |
| Disease | thyroxine measurement | 2.72e-07 | 83 | 20 | 4 | EFO_0005130 | |
| Disease | hormone measurement | 2.86e-07 | 84 | 20 | 4 | EFO_0004730 | |
| Disease | cholelithiasis | 3.45e-07 | 88 | 20 | 4 | EFO_0004799 | |
| Disease | gallstones | 7.86e-07 | 108 | 20 | 4 | EFO_0004210 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 2.69e-06 | 147 | 20 | 4 | DOID:9352 (biomarker_via_orthology) | |
| Disease | bilirubin measurement | 9.49e-06 | 442 | 20 | 5 | EFO_0004570 | |
| Disease | dodecanedioate measurement | 2.87e-05 | 12 | 20 | 2 | EFO_0021054 | |
| Disease | vitamin D measurement | 6.93e-05 | 336 | 20 | 4 | EFO_0004631 | |
| Disease | non-high density lipoprotein cholesterol measurement | 9.32e-05 | 713 | 20 | 5 | EFO_0005689 | |
| Disease | free androgen index | 1.05e-04 | 374 | 20 | 4 | EFO_0007005 | |
| Disease | serum gamma-glutamyl transferase measurement | 2.97e-04 | 914 | 20 | 5 | EFO_0004532 | |
| Disease | urinary bladder carcinoma | 4.63e-04 | 47 | 20 | 2 | MONDO_0004986 | |
| Disease | metabolite measurement | 4.88e-04 | 560 | 20 | 4 | EFO_0004725 | |
| Disease | urate measurement, bone density | 7.11e-04 | 619 | 20 | 4 | EFO_0003923, EFO_0004531 | |
| Disease | apolipoprotein B measurement | 9.19e-04 | 663 | 20 | 4 | EFO_0004615 | |
| Disease | temporal horn of lateral ventricle volume measurement | 1.08e-03 | 72 | 20 | 2 | EFO_0010333 | |
| Disease | testosterone measurement | 1.35e-03 | 1275 | 20 | 5 | EFO_0004908 | |
| Disease | depressive symptom measurement, response to antidepressant | 1.61e-03 | 88 | 20 | 2 | EFO_0007006, GO_0036276 | |
| Disease | attention deficit hyperactivity disorder | 1.68e-03 | 354 | 20 | 3 | EFO_0003888 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.82e-03 | 364 | 20 | 3 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VLFILLCCLYRLCKK | 686 | Q9UKF5 | |
| VCKGLYRALCIREKY | 136 | P23109 | |
| AKGDYLRCCKICYPL | 61 | O75071 | |
| CYLKLREYTKAVECC | 326 | Q13451 | |
| FYLKCCKIRYCNLEG | 111 | Q17RY6 | |
| RVYYICIVCKRSYVC | 491 | Q86T24 | |
| YLCEFCLKYGRSLKC | 261 | Q92993 | |
| RRDCYKYQCAKCRES | 2416 | Q7Z7M0 | |
| KCYKNGICRLECYES | 31 | Q4QY38 | |
| LRIKILGDCYYCICG | 361 | O60266 | |
| YCKRDYVRLFGIKCA | 76 | Q96A47 | |
| ALRKCCYGYCIDLLE | 471 | O60391 | |
| CCAYGYRKCLGKKGR | 506 | Q9HAW8 | |
| VIYECNICGARYKKR | 641 | Q5T1R4 | |
| CCAYGYRKCLGKKGR | 506 | O60656 | |
| IYTCEKLYKCQECDR | 221 | Q8TD23 | |
| YKKCGCENLQLRKYC | 71 | Q9P255 | |
| VYKCIKRLDGCVYAI | 226 | P0C1S8 | |
| CCAYGYRKCLGKKGR | 506 | Q9HAW7 | |
| CCAYGYRKCLGKKGR | 506 | Q9HAW9 | |
| LCEKCKVLGYYCRRV | 226 | Q8N2G6 |